About: Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications
Creator	Molinari, Marco Manto, Mario Mitoma, Hiroshi Schmahmann, Jeremy Be, Mmanto@ulb Dupre, Nicolas Frank, & Hadjivassiliou, Marios Louis, Elan Overwalle, Van Shaikh, Aasef Soong, Bing-Wen Strupp, Michael
Source	Medline; PMC; WHO
abstract	The current worldwide severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic that causes coronavirus disease 2019 (COVID-19) has brought some medical systems to the brink of collapse. This crisis is also negatively impacting the care of patients with non-COVID-19 conditions, including those with cerebellar ataxia (CA). Older patients with CA and those with immune-mediated ataxias on immunosuppressive medication are potentially at high risk of developing serious complications of the infection, although it is also possible that immunosuppressive agents may provide a defense against cytokine storm. This has implications for even greater attention to preventing contracting the disease through physical distancing and/or isolation. The CA patient population is also at higher risk because of the neurological complexities of their underlying disorder and the comorbid medical illnesses that often accompany the genetic ataxias. As the disruption of social patterns and healthcare delivery in response to the crisis continues, interruption of rehabilitation, speech and language therapy, and face-to-face consultations threatens to have a negative impact on the course and well-being of CA patients. Mental and physical health is also potentially at greater risk because the prevailing uncertainty and anxiety may be superimposed upon cerebellum-specific neuropsychological challenges. We identify and review some of the short- and long-term consequences of this global pandemic for the community of ataxia patients and their families and for the clinical and academic neurologists/ataxiologists caring for these patients. This includes the recognition that telemedicine has emerged as a principle means of caregiver-patient contact and that neurological manifestations of COVID-19 including those specific to cerebellar neurobiology are increasingly recognized and will require close surveillance and monitoring. This COVID-19 Cerebellum Task Force consensus provides some guidance on how we may approach this uncertain time and consider preparing for the new realities we face in CA patient care once this acute crisis has passed.
has issue date	2020-05-13(xsd:dateTime)
bibo:doi	10.1007/s12311-020-01139-1
bibo:pmid	32410881
has license	no-cc
sha1sum (hex)	ed7b32f74c085f87817643d0a42a7831ce6c6881
schema:url	https://doi.org/10.1007/s12311-020-01139-1
resource representing a document's title	Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications
has PubMed Central identifier	PMC7220536
has PubMed identifier	32410881
schema:publication	Cerebellum
resource representing a document's body	covid:ed7b32f74c085f87817643d0a42a7831ce6c6881#body_text
is schema:about of	named entity 'identify' named entity 'contact' named entity 'genetic' named entity 'close' named entity 'realities' named entity 'acute' named entity 'neurological' named entity 'Cerebellum' named entity 'preventing' named entity 'illnesses' named entity 'Cerebellar' named entity 'CAUSES' named entity 'RESPONSE TO' named entity 'INTERRUPTION' named entity 'CONDITIONS' named entity 'POSSIBLE' named entity 'NEGATIVE' named entity 'COVID-19' named entity 'FAMILIES' named entity 'DEFENSE' named entity 'MEDICATION' named entity 'MONITORING' named entity 'ACUTE' named entity 'CARING' named entity 'MEDICAL' named entity 'PATIENT POPULATION' named entity 'COMORBID' named entity 'GENETIC' named entity 'UNCERTAIN' named entity 'ATTENTION' named entity 'PANDEMIC' covid:arg/ed7b32f74c085f87817643d0a42a7831ce6c6881 named entity 'interruption' named entity 'consequences' named entity 'cerebellar' named entity 'high risk' named entity 'well-being' named entity 'social' named entity 'language' named entity 'attention' named entity 'neurologists' named entity 'pandemic' named entity 'current' named entity 'global' named entity 'COVID-19' named entity 'COVID-19' named entity 'patient care' named entity 'neurological' named entity 'ataxia' named entity 'cerebellar' named entity 'caregiver' named entity 'immunosuppressive medication' named entity 'face' named entity 'Task Force' named entity 'rituximab' named entity 'IL-1' named entity 'flatten the curve' named entity 'intensivists' named entity 'Neurological' named entity 'infection' named entity 'aspiration pneumonia' named entity 'ICU' named entity 'infection' named entity 'IL-6' named entity 'non-clinical' named entity 'respiration' named entity 'Fatigue' named entity 'COVID' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software